Advertisement

Topics

Idhifa approved for some with acute myeloid leukemia

11:10 EDT 1 Aug 2017 | Medical Xpress

(HealthDay)—Idhifa (enasidenib) has been approved by the U.S. Food and Drug Administration to treat adults with a specific genetic mutation that leads to relapsed or refractory acute myeloid leukemia (AML).

Original Article: Idhifa approved for some with acute myeloid leukemia

NEXT ARTICLE

More From BioPortfolio on "Idhifa approved for some with acute myeloid leukemia"

Quick Search
Advertisement
 

Relevant Topic

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...